Literature DB >> 10900349

PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia.

I Nelissen1, P Fiten, K Vandenbroeck, J Hillert, T Olsson, M G Marrosu, G Opdenakker.   

Abstract

Using genome screen, DNA sequence and mapping data, we scanned the human chromosomal region 17q21-q24 for polymorphic markers in single copy genes. Three such genes were identified: the gene for myeloperoxidase (MPO) at 17q21.3-q23.2, containing a CA-microsatellite in the eighth intron and a functional single base substitution (G to A) in the promoter region, the platelet endothelial cell adhesion molecule-1 gene (PECAM1) at 17q23, which has a CA-repeat sequence in the sixth intron, and the gene for the regulatory subunit RIalpha of cAMP-dependent protein kinase (PRKAR1A) at 17q23-q24, in which a GA-microsatellite was detected in the 5'-flanking region. Association of these polymorphisms with multiple sclerosis (MS) was studied in a Swedish case-control population of 199 MS patients and 145 control subjects, and in 203 simplex families from Sardinia. None of these polymorphic genes was found to be a genetic marker for disease susceptibility. These results are in contrast with previous studies on the involvement of MPO in MS and suggest that the elevated expression of PECAM-1 in MS, as earlier documented, is related to transactivation by other gene products.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900349     DOI: 10.1016/s0165-5728(00)00293-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.

Authors:  Reza Forghani; Gregory R Wojtkiewicz; Yinian Zhang; Daniel Seeburg; Benjamin R M Bautz; Benjamin Pulli; Andrew R Milewski; Wendy L Atkinson; Yoshiko Iwamoto; Elizabeth R Zhang; Martin Etzrodt; Elisenda Rodriguez; Clinton S Robbins; Filip K Swirski; Ralph Weissleder; John W Chen
Journal:  Radiology       Date:  2012-03-21       Impact factor: 11.105

Review 2.  Role of platelets in neuroinflammation: a wide-angle perspective.

Authors:  Lawrence L Horstman; Wenche Jy; Yeon S Ahn; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; J Steven Alexander; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2010-02-03       Impact factor: 8.322

3.  Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms.

Authors:  Emily K Reinke; Jangeun Lee; Alla Zozulya; Jozsef Karman; William A Muller; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neuroimmunol       Date:  2007-04-27       Impact factor: 3.478

4.  Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis.

Authors:  I Manna; P Valentino; A La Russa; F Condino; R Nisticò; M Liguori; A Clodomiro; V Andreoli; D Pirritano; R Cittadella; A Quattrone
Journal:  J Negat Results Biomed       Date:  2006-02-27

5.  PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation.

Authors:  Isabella Wimmer; Silvia Tietz; Hideaki Nishihara; Urban Deutsch; Federica Sallusto; Fabien Gosselet; Ruth Lyck; William A Muller; Hans Lassmann; Britta Engelhardt
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.